Dexcom, Inc. is a prominent American medical technology company based in San Diego, California, founded in 1999. The company specializes in developing, manufacturing, and distributing continuous glucose monitoring (CGM) systems that assist individuals with diabetes in managing their blood glucose levels effectively. Dexcom's mission is to empower users through innovative technology that provides real-time glucose data, enhancing disease management and quality of life.

The flagship products include the Dexcom G6 and G7 CGM systems, which feature small sensors that continuously measure glucose levels and wirelessly transmit data to smartphones or dedicated receivers. These systems eliminate the need for routine fingerstick calibrations and can integrate with insulin pumps and other digital health platforms. Dexcom also offers software and mobile applications for monitoring glucose trends and making informed treatment decisions. The company serves a diverse customer base, including individuals with Type 1 and Type 2 diabetes, children, and pregnant women, with its technology available in over 50 countries.